Trinity Biotech plc

TRIB · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$6,042-$8,804-$16,956-$4,759
Dep. & Amort.$665$638$424$598
Deferred Tax$0$0$585-$35
Stock-Based Comp.$0$0$140$250
Change in WC$1,079$3,065$8,537-$1,880
Other Non-Cash$2,628$2,138$10,621$2,202
Operating Cash Flow-$1,671-$2,962$3,351-$3,624
Investing Activities
PP&E Inv.-$1,996-$1,983-$157-$110
Net Acquisitions$0$0-$1-$403
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$2,579-$2,589
Investing Cash Flow-$1,996-$1,983-$2,737-$3,102
Financing Activities
Debt Repay.$1,894$4,003$1,336-$678
Stock Issued$3$548$544$7,117
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$805-$737-$74-$2,195
Financing Cash Flow$1,092$3,815$1,806$4,244
Forex Effect$55$30-$93$5
Net Chg. in Cash-$2,520-$1,101$2,327-$2,477
Supplemental Information
Beg. Cash$4,066$5,167$2,840$5,317
End Cash$1,546$4,066$5,167$2,840
Free Cash Flow-$1,708-$3,018$615-$6,323
Trinity Biotech plc (TRIB) Financial Statements & Key Stats | AlphaPilot